Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-004250
Filing Date
2021-04-14
Accepted
2021-04-14 08:31:41
Documents
75
Period of Report
2021-02-28

Document Format Files

Seq Description Document Type Size
1 10-Q tmb-20210228x10q.htm   iXBRL 10-Q 2274238
2 EX-10.4 tmb-20210228xex10d4.htm EX-10.4 114212
3 EX-31.1 tmb-20210228xex31d1.htm EX-31.1 9511
4 EX-31.2 tmb-20210228xex31d2.htm EX-31.2 9455
5 EX-32.1 tmb-20210228xex32d1.htm EX-32.1 5492
6 EX-32.2 tmb-20210228xex32d2.htm EX-32.2 5497
  Complete submission text file 0001558370-21-004250.txt   8933319

Data Files

Seq Description Document Type Size
7 EX-101.SCH tmb-20210228.xsd EX-101.SCH 65138
8 EX-101.CAL tmb-20210228_cal.xml EX-101.CAL 51107
9 EX-101.DEF tmb-20210228_def.xml EX-101.DEF 274774
10 EX-101.LAB tmb-20210228_lab.xml EX-101.LAB 490244
11 EX-101.PRE tmb-20210228_pre.xml EX-101.PRE 456069
12 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20210228x10q_htm.xml XML 1319515
Mailing Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660
Business Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 360-980-8524
CytoDyn Inc. (Filer) CIK: 0001175680 (see all company filings)

EIN.: 753056237 | State of Incorp.: DE | Fiscal Year End: 0531
Type: 10-Q | Act: 34 | File No.: 000-49908 | Film No.: 21824596
SIC: 2834 Pharmaceutical Preparations